RxDoctor Payments Data

Daniel Nelson, MD

Interventional Pain Medicine · Kirkland, WANPI 1205878469

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Boston Scientific at 49.7% of the total. Reporting peaked in 2019 at $8,944 and has fallen 60.7% since, to $3,516 in 2025. Among interventional pain medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,314in general payments, 2019–2025

Across 319 payments — averaging $91.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$15K
  • Si-bone, Inc.$6K
  • Nalu Medical, Inc.$2K
  • MML US, Inc.$2K
  • Vertiflex, Inc.$1K
  • Relievant Medsystems, Inc.$912
  • plus $3K from 24 others

What the payments were for

  • Consulting fees$5,60019%
  • Speaking & faculty fees$6,00020%
  • Travel & lodging$5,16618%
  • Food & beverage$12,54843%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific196$14,561
Si-bone, Inc.4$5,704
Nalu Medical, Inc.15$1,809
MML US, Inc.6$1,621
Vertiflex, Inc.15$1,425
Relievant Medsystems, Inc.5$912
Nevro Corp.16$827
Biotronik NRO, Inc.7$452
Biotronik Inc.2$448
Painteq LLC4$264
Vertos Medical, Inc.7$253
Medtronic(2 entities)6$195
Zyla Life Sciences, Inc.10$177
Foundation Fusion Solutions, LLC1$110
Abbott3$84
Stryker1$68
Assertio Therapeutics, Inc.4$67
Bioventus LLC3$52
Stimwave Technologies Incorporated2$40
Saluda Medical Americas, Inc.2$30
Fidia Pharma USA Inc.1$28
Amgen1$27
Vertex1$25
Curonix LLC1$25
Daiichi Sankyo Inc.1$24
Stratus Medical, LLC1$21
Scilex Pharmaceuticals Inc.1$20
Sentynl Therapeutics, Inc.1$15
Pernix Therapeutics Holdings, Inc.1$14
Invictus Surgical Incorporated1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,314 in reported general payments places this provider in the 95th percentile of 30 interventional pain medicine providers in Washington.

See all interventional pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$283,778
Medicare patients
311
Services billed
2,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →